Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition causes the gland to enlarge and, as a result, press against the urethra, constricting urine flow. This disorder is associated with aging, hormone imbalances, and abnormal cell growth.
The global benign prostatic hyperplasia market is expected to show considerable growth during the forecast period. This is attributed to rising geriatric population, increased awareness for prostate cancer and other urological disorders. However, the factors such as dearth of urologist in developing economies and lack of awareness regarding various urological diseases can hinder the growth of the market in the coming years. North America is account for the largest share of the benign prostatic hyperplasia market in 2016 due to high prevalence rate of benign prostatic hyperplasia. However, Asia is the fastest growing market due to the rise in various urological disorders and complications
In 2019, the market size of Benign Prostatic Hyperplasia Devices is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Benign Prostatic Hyperplasia Devices.
This report studies the global market size of Benign Prostatic Hyperplasia Devices, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Benign Prostatic Hyperplasia Devices production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Lumenis
Olympus corporation
Urologix
Boston Scientific corporation
Lisa Laser
Medifocus
Neotrac
ProArc Medical LTD
Urotech GMBH
Market Segment by Product Type
Transurethral Resection of the Prostate (TURP)
Transurethral Microwave Therapy (TUMT)
Transurethral Needle Ablation of the Prostate (TUNA)
Laser Surgery
Prostatic Stenting
Others
Market Segment by Application
Hospitals and Clinics
Ambulatory Surgical Centers(ASC)
Home
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Benign Prostatic Hyperplasia Devices status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Benign Prostatic Hyperplasia Devices manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Benign Prostatic Hyperplasia Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
The global benign prostatic hyperplasia market is expected to show considerable growth during the forecast period. This is attributed to rising geriatric population, increased awareness for prostate cancer and other urological disorders. However, the factors such as dearth of urologist in developing economies and lack of awareness regarding various urological diseases can hinder the growth of the market in the coming years. North America is account for the largest share of the benign prostatic hyperplasia market in 2016 due to high prevalence rate of benign prostatic hyperplasia. However, Asia is the fastest growing market due to the rise in various urological disorders and complications
In 2019, the market size of Benign Prostatic Hyperplasia Devices is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Benign Prostatic Hyperplasia Devices.
This report studies the global market size of Benign Prostatic Hyperplasia Devices, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Benign Prostatic Hyperplasia Devices production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Lumenis
Olympus corporation
Urologix
Boston Scientific corporation
Lisa Laser
Medifocus
Neotrac
ProArc Medical LTD
Urotech GMBH
Market Segment by Product Type
Transurethral Resection of the Prostate (TURP)
Transurethral Microwave Therapy (TUMT)
Transurethral Needle Ablation of the Prostate (TUNA)
Laser Surgery
Prostatic Stenting
Others
Market Segment by Application
Hospitals and Clinics
Ambulatory Surgical Centers(ASC)
Home
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Benign Prostatic Hyperplasia Devices status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Benign Prostatic Hyperplasia Devices manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Benign Prostatic Hyperplasia Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Benign Prostatic Hyperplasia Devices Market Size Growth Rate by Type (2019-2025)
1.3.2 Transurethral Resection of the Prostate (TURP)
1.3.3 Transurethral Microwave Therapy (TUMT)
1.3.4 Transurethral Needle Ablation of the Prostate (TUNA)
1.3.5 Laser Surgery
1.3.6 Prostatic Stenting
1.3.7 Others
1.4 Market Segment by Application
1.4.1 Global Benign Prostatic Hyperplasia Devices Market Share by Application (2019-2025)
1.4.2 Hospitals and Clinics
1.4.3 Ambulatory Surgical Centers(ASC)
1.4.4 Home
1.4.5 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Benign Prostatic Hyperplasia Devices Production Value 2014-2025
2.1.2 Global Benign Prostatic Hyperplasia Devices Production 2014-2025
2.1.3 Global Benign Prostatic Hyperplasia Devices Capacity 2014-2025
2.1.4 Global Benign Prostatic Hyperplasia Devices Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Benign Prostatic Hyperplasia Devices Market Size CAGR of Key Regions
2.2.2 Global Benign Prostatic Hyperplasia Devices Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Benign Prostatic Hyperplasia Devices Capacity by Manufacturers
3.1.2 Global Benign Prostatic Hyperplasia Devices Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Benign Prostatic Hyperplasia Devices Revenue by Manufacturers (2014-2019)
3.2.2 Benign Prostatic Hyperplasia Devices Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Benign Prostatic Hyperplasia Devices Market Concentration Ratio (CR5 and HHI)
3.3 Benign Prostatic Hyperplasia Devices Price by Manufacturers
3.4 Key Manufacturers Benign Prostatic Hyperplasia Devices Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Benign Prostatic Hyperplasia Devices Market
3.6 Key Manufacturers Benign Prostatic Hyperplasia Devices Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Transurethral Resection of the Prostate (TURP) Production and Production Value (2014-2019)
4.1.2 Transurethral Microwave Therapy (TUMT) Production and Production Value (2014-2019)
4.1.3 Transurethral Needle Ablation of the Prostate (TUNA) Production and Production Value (2014-2019)
4.1.4 Laser Surgery Production and Production Value (2014-2019)
4.1.5 Prostatic Stenting Production and Production Value (2014-2019)
4.1.6 Others Production and Production Value (2014-2019)
4.2 Global Benign Prostatic Hyperplasia Devices Production Market Share by Type
4.3 Global Benign Prostatic Hyperplasia Devices Production Value Market Share by Type
4.4 Benign Prostatic Hyperplasia Devices Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Benign Prostatic Hyperplasia Devices Consumption by Application
6 Production by Regions
6.1 Global Benign Prostatic Hyperplasia Devices Production (History Data) by Regions 2014-2019
6.2 Global Benign Prostatic Hyperplasia Devices Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Benign Prostatic Hyperplasia Devices Production Growth Rate 2014-2019
6.3.2 United States Benign Prostatic Hyperplasia Devices Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States Benign Prostatic Hyperplasia Devices Import & Export
6.4 European Union
6.4.1 European Union Benign Prostatic Hyperplasia Devices Production Growth Rate 2014-2019
6.4.2 European Union Benign Prostatic Hyperplasia Devices Production Value Growth Rate 2014-2019
6.4.3 Key Players in European Union
6.4.4 European Union Benign Prostatic Hyperplasia Devices Import & Export
6.5 China
6.5.1 China Benign Prostatic Hyperplasia Devices Production Growth Rate 2014-2019
6.5.2 China Benign Prostatic Hyperplasia Devices Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Benign Prostatic Hyperplasia Devices Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Benign Prostatic Hyperplasia Devices Consumption by Regions
7.1 Global Benign Prostatic Hyperplasia Devices Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Benign Prostatic Hyperplasia Devices Consumption by Type
7.2.2 United States Benign Prostatic Hyperplasia Devices Consumption by Application
7.3 European Union
7.3.1 European Union Benign Prostatic Hyperplasia Devices Consumption by Type
7.3.2 European Union Benign Prostatic Hyperplasia Devices Consumption by Application
7.4 China
7.4.1 China Benign Prostatic Hyperplasia Devices Consumption by Type
7.4.2 China Benign Prostatic Hyperplasia Devices Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Benign Prostatic Hyperplasia Devices Consumption by Type
7.5.2 Rest of World Benign Prostatic Hyperplasia Devices Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Lumenis
8.1.1 Lumenis Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Benign Prostatic Hyperplasia Devices
8.1.4 Benign Prostatic Hyperplasia Devices Product Introduction
8.1.5 Lumenis Recent Development
8.2 Olympus corporation
8.2.1 Olympus corporation Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Benign Prostatic Hyperplasia Devices
8.2.4 Benign Prostatic Hyperplasia Devices Product Introduction
8.2.5 Olympus corporation Recent Development
8.3 Urologix
8.3.1 Urologix Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Benign Prostatic Hyperplasia Devices
8.3.4 Benign Prostatic Hyperplasia Devices Product Introduction
8.3.5 Urologix Recent Development
8.4 Boston Scientific corporation
8.4.1 Boston Scientific corporation Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Benign Prostatic Hyperplasia Devices
8.4.4 Benign Prostatic Hyperplasia Devices Product Introduction
8.4.5 Boston Scientific corporation Recent Development
8.5 Lisa Laser
8.5.1 Lisa Laser Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Benign Prostatic Hyperplasia Devices
8.5.4 Benign Prostatic Hyperplasia Devices Product Introduction
8.5.5 Lisa Laser Recent Development
8.6 Medifocus
8.6.1 Medifocus Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Benign Prostatic Hyperplasia Devices
8.6.4 Benign Prostatic Hyperplasia Devices Product Introduction
8.6.5 Medifocus Recent Development
8.7 Neotrac
8.7.1 Neotrac Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Benign Prostatic Hyperplasia Devices
8.7.4 Benign Prostatic Hyperplasia Devices Product Introduction
8.7.5 Neotrac Recent Development
8.8 ProArc Medical LTD
8.8.1 ProArc Medical LTD Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Benign Prostatic Hyperplasia Devices
8.8.4 Benign Prostatic Hyperplasia Devices Product Introduction
8.8.5 ProArc Medical LTD Recent Development
8.9 Urotech GMBH
8.9.1 Urotech GMBH Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Benign Prostatic Hyperplasia Devices
8.9.4 Benign Prostatic Hyperplasia Devices Product Introduction
8.9.5 Urotech GMBH Recent Development
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Benign Prostatic Hyperplasia Devices Capacity, Production Forecast 2019-2025
9.1.2 Global Benign Prostatic Hyperplasia Devices Production Value Forecast 2019-2025
9.2 Market Forecast by Regions
9.2.1 Global Benign Prostatic Hyperplasia Devices Production and Value Forecast by Regions 2019-2025
9.2.2 Global Benign Prostatic Hyperplasia Devices Consumption Forecast by Regions 2019-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Benign Prostatic Hyperplasia Devices Production Forecast by Type
9.7.2 Global Benign Prostatic Hyperplasia Devices Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Benign Prostatic Hyperplasia Devices Sales Channels
10.2.2 Benign Prostatic Hyperplasia Devices Distributors
10.3 Benign Prostatic Hyperplasia Devices Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter''s Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Benign Prostatic Hyperplasia Devices Market Size Growth Rate by Type (2019-2025)
1.3.2 Transurethral Resection of the Prostate (TURP)
1.3.3 Transurethral Microwave Therapy (TUMT)
1.3.4 Transurethral Needle Ablation of the Prostate (TUNA)
1.3.5 Laser Surgery
1.3.6 Prostatic Stenting
1.3.7 Others
1.4 Market Segment by Application
1.4.1 Global Benign Prostatic Hyperplasia Devices Market Share by Application (2019-2025)
1.4.2 Hospitals and Clinics
1.4.3 Ambulatory Surgical Centers(ASC)
1.4.4 Home
1.4.5 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Benign Prostatic Hyperplasia Devices Production Value 2014-2025
2.1.2 Global Benign Prostatic Hyperplasia Devices Production 2014-2025
2.1.3 Global Benign Prostatic Hyperplasia Devices Capacity 2014-2025
2.1.4 Global Benign Prostatic Hyperplasia Devices Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Benign Prostatic Hyperplasia Devices Market Size CAGR of Key Regions
2.2.2 Global Benign Prostatic Hyperplasia Devices Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Benign Prostatic Hyperplasia Devices Capacity by Manufacturers
3.1.2 Global Benign Prostatic Hyperplasia Devices Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Benign Prostatic Hyperplasia Devices Revenue by Manufacturers (2014-2019)
3.2.2 Benign Prostatic Hyperplasia Devices Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Benign Prostatic Hyperplasia Devices Market Concentration Ratio (CR5 and HHI)
3.3 Benign Prostatic Hyperplasia Devices Price by Manufacturers
3.4 Key Manufacturers Benign Prostatic Hyperplasia Devices Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Benign Prostatic Hyperplasia Devices Market
3.6 Key Manufacturers Benign Prostatic Hyperplasia Devices Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Transurethral Resection of the Prostate (TURP) Production and Production Value (2014-2019)
4.1.2 Transurethral Microwave Therapy (TUMT) Production and Production Value (2014-2019)
4.1.3 Transurethral Needle Ablation of the Prostate (TUNA) Production and Production Value (2014-2019)
4.1.4 Laser Surgery Production and Production Value (2014-2019)
4.1.5 Prostatic Stenting Production and Production Value (2014-2019)
4.1.6 Others Production and Production Value (2014-2019)
4.2 Global Benign Prostatic Hyperplasia Devices Production Market Share by Type
4.3 Global Benign Prostatic Hyperplasia Devices Production Value Market Share by Type
4.4 Benign Prostatic Hyperplasia Devices Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Benign Prostatic Hyperplasia Devices Consumption by Application
6 Production by Regions
6.1 Global Benign Prostatic Hyperplasia Devices Production (History Data) by Regions 2014-2019
6.2 Global Benign Prostatic Hyperplasia Devices Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Benign Prostatic Hyperplasia Devices Production Growth Rate 2014-2019
6.3.2 United States Benign Prostatic Hyperplasia Devices Production Value Growth Rate 2014-2019
6.3.3 Key Players in United States
6.3.4 United States Benign Prostatic Hyperplasia Devices Import & Export
6.4 European Union
6.4.1 European Union Benign Prostatic Hyperplasia Devices Production Growth Rate 2014-2019
6.4.2 European Union Benign Prostatic Hyperplasia Devices Production Value Growth Rate 2014-2019
6.4.3 Key Players in European Union
6.4.4 European Union Benign Prostatic Hyperplasia Devices Import & Export
6.5 China
6.5.1 China Benign Prostatic Hyperplasia Devices Production Growth Rate 2014-2019
6.5.2 China Benign Prostatic Hyperplasia Devices Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Benign Prostatic Hyperplasia Devices Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Benign Prostatic Hyperplasia Devices Consumption by Regions
7.1 Global Benign Prostatic Hyperplasia Devices Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Benign Prostatic Hyperplasia Devices Consumption by Type
7.2.2 United States Benign Prostatic Hyperplasia Devices Consumption by Application
7.3 European Union
7.3.1 European Union Benign Prostatic Hyperplasia Devices Consumption by Type
7.3.2 European Union Benign Prostatic Hyperplasia Devices Consumption by Application
7.4 China
7.4.1 China Benign Prostatic Hyperplasia Devices Consumption by Type
7.4.2 China Benign Prostatic Hyperplasia Devices Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Benign Prostatic Hyperplasia Devices Consumption by Type
7.5.2 Rest of World Benign Prostatic Hyperplasia Devices Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Lumenis
8.1.1 Lumenis Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Benign Prostatic Hyperplasia Devices
8.1.4 Benign Prostatic Hyperplasia Devices Product Introduction
8.1.5 Lumenis Recent Development
8.2 Olympus corporation
8.2.1 Olympus corporation Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Benign Prostatic Hyperplasia Devices
8.2.4 Benign Prostatic Hyperplasia Devices Product Introduction
8.2.5 Olympus corporation Recent Development
8.3 Urologix
8.3.1 Urologix Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Benign Prostatic Hyperplasia Devices
8.3.4 Benign Prostatic Hyperplasia Devices Product Introduction
8.3.5 Urologix Recent Development
8.4 Boston Scientific corporation
8.4.1 Boston Scientific corporation Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Benign Prostatic Hyperplasia Devices
8.4.4 Benign Prostatic Hyperplasia Devices Product Introduction
8.4.5 Boston Scientific corporation Recent Development
8.5 Lisa Laser
8.5.1 Lisa Laser Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Benign Prostatic Hyperplasia Devices
8.5.4 Benign Prostatic Hyperplasia Devices Product Introduction
8.5.5 Lisa Laser Recent Development
8.6 Medifocus
8.6.1 Medifocus Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Benign Prostatic Hyperplasia Devices
8.6.4 Benign Prostatic Hyperplasia Devices Product Introduction
8.6.5 Medifocus Recent Development
8.7 Neotrac
8.7.1 Neotrac Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Benign Prostatic Hyperplasia Devices
8.7.4 Benign Prostatic Hyperplasia Devices Product Introduction
8.7.5 Neotrac Recent Development
8.8 ProArc Medical LTD
8.8.1 ProArc Medical LTD Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Benign Prostatic Hyperplasia Devices
8.8.4 Benign Prostatic Hyperplasia Devices Product Introduction
8.8.5 ProArc Medical LTD Recent Development
8.9 Urotech GMBH
8.9.1 Urotech GMBH Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Benign Prostatic Hyperplasia Devices
8.9.4 Benign Prostatic Hyperplasia Devices Product Introduction
8.9.5 Urotech GMBH Recent Development
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Benign Prostatic Hyperplasia Devices Capacity, Production Forecast 2019-2025
9.1.2 Global Benign Prostatic Hyperplasia Devices Production Value Forecast 2019-2025
9.2 Market Forecast by Regions
9.2.1 Global Benign Prostatic Hyperplasia Devices Production and Value Forecast by Regions 2019-2025
9.2.2 Global Benign Prostatic Hyperplasia Devices Consumption Forecast by Regions 2019-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Benign Prostatic Hyperplasia Devices Production Forecast by Type
9.7.2 Global Benign Prostatic Hyperplasia Devices Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Benign Prostatic Hyperplasia Devices Sales Channels
10.2.2 Benign Prostatic Hyperplasia Devices Distributors
10.3 Benign Prostatic Hyperplasia Devices Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter''s Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
